Sprouts Q1 2026 Sales Outlook and Strategic Initiatives for Margin Growth

Centene’s strategies to improve Medicaid margin in Q1 2026 (and carry forward in 2026)

Centene’s Medicaid margin improvement plan in Q1 2026 is fundamentally a trend-and-cost-management program paired with rate/yield discipline and payment integrity/fraud controls, supported by operational modernization and state-program alignment. Management explicitly tied Q1 progress to “targeted and increasingly scaled initiatives” to manage medical cost trend and modernize processes. ¹

1) Deliver Medicaid medical-cost trend outperformance (HBR improvement through execution)

Centene reported that Medicaid HBR was 93.1% in Q1 2026, up from no—rather, it was an improvement of 50 basis points vs. Q1 2025, and management characterized this as “continued progress” toward returning Medicaid to a “reasonable Medicaid margin.” ²

Management attributed the Medicaid beat to both temporary drivers and core fundamentals:

• Flu season lighter than forecast and slight utilization benefit from weather events. ¹
• More “fundamental outperformance” driven by “disciplined execution on trend management initiatives across the portfolio.” ¹

This is consistent with the broader guidance framing that Medicaid margin recovery is driven by net trend (medical costs net of initiatives) and outperformance of that target, with network optimization, scaling clinical programs, and payment integrity/fraud/waste/abuse work named as key levers. ³⁴

2) Run a multi-tenet trend-management program (network + clinical + payment integrity)

In the call, Centene described Medicaid outperformance in Q1 as the result of a “consistent sort of multi-tenet program” deployed over roughly the last 1.5 years, with specific levers including:

• Network optimization. ³
• Further scaling clinical programs. ³
• Payment integrity and fraud, waste, and abuse work. ³

Management also emphasized that it is not just cost-cutting; it’s part of a sustained program execution that is producing measurable HBR results (Medicaid HBR progress in Q1 and “third consecutive quarter of progress toward that goal”). ²¹

3) Modernize and standardize processes to manage medical cost trend

Centene explicitly linked margin improvement to modernizing and standardizing processes to “better manage medical cost trend.” ¹

In other words, the Medicaid strategy is not only tactical clinical programs; it includes operational process transformation intended to make trend management more systematic and scalable across the portfolio. ¹

4) Improve payment accuracy and earlier detection of abnormal/fraudulent utilization

Centene said it is “deploying advanced analytics and selective AI-enabled tools across forecasting, medical economics and payment integrity,” using those capabilities as an independent validation layer alongside traditional forecasting. ⁵

The stated purpose is to:

• bring in “more timely data” into evaluation of emerging medical trend, and ⁵
• identify “fraud, waste and abnormal claims behavior earlier,” improving prioritization and “more disciplined cost management.” ⁵

This is directly aligned with the Medicaid margin drivers management listed elsewhere: payment integrity and fraud/waste/abuse controls. ³

5) Use increased state alignment to translate program acuity into program revenue (rates/yield + program changes)

Centene’s margin plan also relies on ensuring that program revenue aligns with member acuity and outcomes, especially as states implement policy changes.

Key elements management highlighted:

• Composite rate yield expected around ~4.5% and “conversations with Medicaid departments remain constructive.” ⁶
• Centene continues to “present refreshed data and… programmatic solutions” to state partners to help states balance “costs and benefits” in Medicaid. ⁶
• States are increasingly taking “program changes” that clarify benefit design and enable MCOs to use Centene’s “data-driven approach” to deliver “highest quality, lowest cost care,” aiming to improve the “margin profile.” ⁷

Management specifically tied Q1 Medicaid outperformance momentum to the idea that states are reflecting base trend in acuity data in rates and working with Centene to shape “successful and sustainable programs.” ¹

6) Leverage prior authorization improvements as a cost/quality lever

Centene highlighted progress against prior authorization commitments, describing the industry-wide work as making prior authorization “faster, easier and less expensive.” ⁸

Centene framed this as part of “self disrupting” (not self-regulating), which aligns conceptually with reducing avoidable high-cost utilization while supporting appropriate care—though Centene did not quantify the exact margin impact in the excerpt. ⁸

7) Manage expectations: Q1 beat is already partly “planning-outperformance,” but not relied upon mechanically

Management stated that while they saw better-than-assumed performance in Q1, they are not counting on continued outperformance to the same extent; instead, they believe the fundamental drivers make the outlook “leans positive.” ³

They described a potential trajectory where results could land “15 or 20 basis points ahead” of a referenced benchmark HBR of 93.7%. ³
Separately, Centene stated overall confidence is anchored to the strategy that net trend remains in the mid-4% range with continued execution. ⁶⁴

---

Bottom line

In Q1 2026, Centene’s Medicaid margin improvement strategy combined:

1. Visible HBR progress (Medicaid HBR 93.1%, +50 bps improvement vs. Q1 2025). ²
2. Structured trend-management levers: network optimization, clinical program scaling, and payment integrity/fraud-waste-abuse initiatives. ³
3. Operational modernization: modernize/standardize processes to better manage medical cost trend. ¹
4. Advanced analytics/AI in payment integrity and forecasting validation, enabling earlier detection of abnormal or improper claims patterns. ⁵
5. State alignment on rates/yield and acuity, supported by refreshed data and programmatic solutions; plus supportive policy mechanics like prior authorization improvements. ⁶⁸

Collectively, these strategies are what management said are “bearing fruit” in Q1 and are intended to sustain margin recovery momentum through 2026 and beyond. ¹⁵³